Leukemia Research - Search Results

327 Periodical Search Results
You searched for "cytarabine" within Leukemia Research
New Search \| Edit Search \| Save Search \| Save Search as an E-mail Alert
Viewing 1-20 of 327 results Next 20>	Results Page: [1] 2 3 4 5 6 7 >

Display:

	Cytarabine-induced pericarditis: A case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy Sigrun Reykdal, Ronald Sham, Peter Kouides Leukemia Research February 1995 (Vol. 19, Issue 2, Pages 141-144) Abstract \| Abstract + References \| Full-Text PDF (356 KB)
	Evidence for sinoatrial blockade associated with high dose cytarabine therapy Kostas Stamatopoulos, Georgia Kanellopoulou, George Vaiopoulos, George Stamatellos, Xenophon Yataganas Leukemia Research August 1998 (Vol. 22, Issue 8, Pages 759-761) Abstract \| Full Text \| Full-Text PDF (184 KB)
	C-kit receptor expression in acute leukemias—association with patient and disease characteristics and with outcome Anne S Tsao, Hagop Kantarjian, Deborah Thomas, Francis Giles, Jorge Cortes, Guillermo Garcia-Manero, Yang Huh, Ying Yang, Yu Shen, Maher Albitar, Elihu Estey Leukemia Research April 2004 (Vol. 28, Issue 4, Pages 373-378) Abstract \| Full Text \| Full-Text PDF (98 KB)
	Will cyclopentenyl cytosine (CPEC) ever have a future in the clinic? Chris van Bree, André B.P. van Kuilenburg Leukemia Research February 2008 (Vol. 32, Issue 2, Pages 201-202) Full Text \| Full-Text PDF (73 KB)
	First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients Pier Paolo Piccaluga, Giovanni Martinelli, Michela Rondoni, Michele Malagola, Stavroula Gaitani, Giuseppe Visani, Michele Baccarani Leukemia Research September 2004 (Vol. 28, Issue 9, Pages 987-990) Abstract \| Full Text \| Full-Text PDF (53 KB)
	Combination chemotherapy utilizing continuous infusion of intermediate-dose cytarabine for refractory or recurrent acute myeloid leukemia Hyeseung Bahng, Je-Hwan Lee, Jin-Hee Ahn, Jung-Hee Lee, Jung-Shin Lee, Sang-Hee Kim, Woo-Kun Kim, Kyoo-Hyung Lee Leukemia Research March 2001 (Vol. 25, Issue 3, Pages 213-216) Abstract \| Full Text \| Full-Text PDF (69 KB)
	Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin Karen L. Morris, Julie A. Adams, John A. Liu Yin Leukemia Research August 2009 (Vol. 33, Issue 8, Pages 1096-1099) Abstract \| Full Text \| Full-Text PDF (612 KB)
	Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies Jeffrey E Rubnitz, Bassem I Razzouk, Deo Kumar Srivastava, Ching-Hon Pui, Raul C Ribeiro, Victor M Santana Leukemia Research April 2004 (Vol. 28, Issue 4, Pages 349-352) Abstract \| Full Text \| Full-Text PDF (62 KB)
	Laromustine: The return of alkylators to non-myeloablative therapy of AML Francis J. Giles Leukemia Research August 2009 (Vol. 33, Issue 8, Pages 1022-1023) Full Text \| Full-Text PDF (92 KB)
	A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia Jeffrey E. Lancet, Maria R. Baer, George E. Duran, Alan F. List, Robert Fielding, John F. Marcelletti, Pratik S. Multani, Branimir I. Sikic Leukemia Research August 2009 (Vol. 33, Issue 8, Pages 1055-1061) Abstract \| Full Text \| Full-Text PDF (195 KB)
	Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission Itai Levi, Itamar Grotto, Ronit Yerushalmi, Isaac Ben-Bassat, Ofer Shpilberg Leukemia Research June 2004 (Vol. 28, Issue 6, Pages 605-612) Abstract \| Full Text \| Full-Text PDF (92 KB)
	Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine Pia Raanani, Ofer Shpilberg, Shmuel Gillis, Abraham Avigdor, Izhar Hardan, Miriam Berkowicz, Orit Sofer, Izidore Lossos, Angela Chetrit, Dina Ben-Yehuda, Isaac Ben-Bassat Leukemia Research August 1999 (Vol. 23, Issue 8, Pages 695-700) Abstract \| Full Text \| Full-Text PDF (74 KB)
	Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML Alison R. Walker, Rami S. Komrokji, Jainulabdeen Ifthikharuddin, Patti Messina, Deborah Mulford, Michael Becker, Jonathan Friedberg, Jamie Oliva, Gordon Phillips, Jane L. Liesveld, Camille Abboud Leukemia Research December 2008 (Vol. 32, Issue 12, Pages 1830-1836) Abstract \| Full Text \| Full-Text PDF (208 KB)
	Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents Cecily A. Bennett, Amanda C. Winters, Nisha N. Barretto, Charles S. Hemenway Leukemia Research July 2009 (Vol. 33, Issue 7, Pages 937-947) Abstract \| Full Text \| Full-Text PDF (1421 KB)
	Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia Si-Xuan Qian, Jian-Yong Li, Tian Tian, Yun-Feng Shen, Yuan-Qiang Jiang, Hua Lu, Han-Xin Wu, Su-Jiang Zhang, Wei Xu Leukemia Research October 2007 (Vol. 31, Issue 10, Pages 1383-1388) Abstract \| Full Text \| Full-Text PDF (219 KB)
	Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes Bruce D Cheson Leukemia Research 1 May 1998 (Vol. 22Supplement 1, Pages S17-S21) Abstract \| Full Text \| Full-Text PDF (64 KB)
	Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells C. Lu, H.T. Hassan Leukemia Research March 2006 (Vol. 30, Issue 3, Pages 296-302) Abstract \| Full Text \| Full-Text PDF (116 KB)
	Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project June M. McKoy, Cara Angelotta, Charles L. Bennett, Martin S. Tallman, Martha Wadleigh, Andrew M. Evens, Timothy M. Kuzel, Steve M. Trifilio, Dennis W. Raisch, Jonathan Kell, Daniel J. DeAngelo, Francis J. Giles Leukemia Research May 2007 (Vol. 31, Issue 5, Pages 599-604) Abstract \| Full Text \| Full-Text PDF (128 KB)
	Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome Karen W.L. Yee, Jorge Cortes, Alessandra Ferrajoli, Guillermo Garcia-Manero, Srdan Verstovsek, William Wierda, Deborah Thomas, Stefan Faderl, Ivan King, Susan M. O’Brien, Sima Jeha, Michael Andreeff, Ann Cahill, Mario Sznol, Francis J. Giles Leukemia Research July 2006 (Vol. 30, Issue 7, Pages 813-822) Abstract \| Full Text \| Full-Text PDF (143 KB)
	Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia Je-Hwan Lee, Seong-Jun Choi, Jung-Hee Lee, Young-Shin Lee, Miee Seol, Seong-Gil Ryu, Seongsoo Jang, Chan-Jeoung Park, Hyun-Sook Chi, Jung-Shin Lee, Woo-Kun Kim, Kyoo-Hyung Lee Leukemia Research February 2006 (Vol. 30, Issue 2, Pages 204-210) Abstract \| Full Text \| Full-Text PDF (126 KB)

Display:

Viewing 1-20 of 327 results Next 20>	Results Page: [1] 2 3 4 5 6 7 >
New Search \| Edit Search \| Save Search \| Save Search as an E-mail Alert